Published in Pharmacol Toxicol on July 01, 1997
Hair as a biomarker for exposure to tobacco smoke. Tob Control (2002) 1.63
Detection of third-hand smoke on clothing fibers with a surface acoustic wave gas sensor. Biomicrofluidics (2016) 0.80
[Use of hair nicotine as a tool to assess tobacco smoke exposure]. Przegl Lek (2008) 0.75
Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther (1977) 1.61
Comparison of three methods for estimating environmental tobacco smoke exposure among children aged between 12 and 36 months. Int J Epidemiol (1995) 1.32
Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol (1978) 1.23
Variable binding of propranolol in human serum. Biochem Pharmacol (1979) 1.12
Nicotine in hair of smokers and non-smokers: sampling procedure and gas chromatographic/mass spectrometric analysis. Pharmacol Toxicol (1995) 1.12
Long-term effects of inhaled nicotine. Life Sci (1996) 1.07
Production of discrete changes in dopamine and noradrenaline levels and turnover in various parts of the rat brain following exposure to xylene, ortho-, meta-, and para-xylene, and ethylbenzene. Toxicol Appl Pharmacol (1981) 1.05
In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther (1990) 0.98
Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiency. Arzneimittelforschung (1985) 0.95
Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma. Biochem Pharmacol (1977) 0.94
Inhalation kinetics of C8 to C10 1-alkenes and iso-alkanes in the rat after repeated exposures. Pharmacol Toxicol (1993) 0.92
Uptake of nicotine in hair during controlled environmental air exposure to nicotine vapour: evidence for a major contribution of environmental nicotine to the overall nicotine found in hair from smokers and non-smokers. Pharmacol Toxicol (1995) 0.90
Increased amine turnover in several hypothalamic noradrenaline nerve terminal systems and changes in prolactin secretion in the male rat by exposure to various concentrations of toluene. Neurotoxicology (1983) 0.86
Toluene and telencephalic dopamine: selective reduction of amine turnover in discrete DA nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene. Toxicol Lett (1982) 0.84
Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. Toxicol Lett (1980) 0.84
Changes in rat liver microsomal cytochrome P-450 and enzymatic activities after the inhalation of n-hexane, xylene, methyl ethyl ketone and methylchloroform for four weeks. Scand J Work Environ Health (1981) 0.83
Effect of lifelong nicotine inhalation on bone mass and mechanical properties in female rat femurs. Calcif Tissue Int (1999) 0.83
Interindividual differences in hair uptake of air nicotine and significance of cigarette counting for estimation of environmental tobacco smoke exposure. Pharmacol Toxicol (1996) 0.83
Effects of xylene and xylene isomers on cytochrome P-450 and in vitro enzymatic activities in rat liver, kidney and lung. Toxicology (1982) 0.82
Inhibition of P-glycoprotein in Caco-2 cells: effects of herbal remedies frequently used by cancer patients. Xenobiotica (2008) 0.82
Effect of nicotine on the enterochromaffin like cells of the oxyntic mucosa of the rat. Life Sci (1993) 0.82
The binding of quinidine to protein fractions of normal human sera. Biochem Pharmacol (1975) 0.81
Measurement of HPRT mutations in splenic lymphocytes and haemoglobin adducts in erythrocytes of Lewis rats exposed to ethylene oxide. Mutat Res (1999) 0.80
Differences in the serum protein binding of prazosin in man and rat. Biochem Pharmacol (1984) 0.80
Pharmacokinetics of quinidine related to plasma protein binding in man. Eur J Clin Pharmacol (1979) 0.79
Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma. Cancer Chemother Pharmacol (1987) 0.79
Metabolic interaction of n-hexane and methyl ethyl ketone in vitro in a head space rat liver S9 vial equilibration system. Pharmacol Toxicol (1998) 0.79
A comparison of the binding and distribution of benzo[a]pyrene in human and rat serum. Toxicology (1987) 0.79
Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. Eur J Clin Pharmacol (1983) 0.79
Dose dependent induction of rat liver microsomal cytochrome P-450 and microsomal enzymatic activities after inhalation of toluene and dichloromethane. Acta Pharmacol Toxicol (Copenh) (1982) 0.79
Polychlorinated terphenyls: alterations in liver morphology and induction of cytochrome P-450. Toxicology (1986) 0.78
Increased microsomal metabolism of n-hexane in rat kidney and liver after inhalation of isopropanol. Arch Toxicol Suppl (1984) 0.78
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients. Cancer Chemother Pharmacol (1990) 0.78
Phthalate esters I: Effects on cytochrome P-450 mediated metabolism in rat liver and lung, serum enzymatic activities and serum protein levels. Arch Toxicol (1982) 0.78
Effects of acrylonitrile on rat liver cytochrome P-450, benzo(a)pyrene metabolism and serum hormone levels. Toxicol Lett (1980) 0.78
Effects of polychlorinated terphenyls and paraffins on rat liver microsomal cytochrome P-450 and in vitro metabolic activities. Arch Toxicol (1981) 0.77
Pharmacokinetics of thio-TEPA at two different doses. Cancer Chemother Pharmacol (1988) 0.77
The binding of thio-TEPA in human serum and to isolated serum protein fractions. Cancer Chemother Pharmacol (1987) 0.77
Short-term exposure of rodents to diesel exhausts: usefulness for studies of genotoxic and immunotoxic effects. Chem Biol Interact (1999) 0.77
Correlation between changes in enzymatic activities and induction of different forms of rat liver microsomal cytochrome P-450 after phenobarbital-, 3-methylcholanthrene- and 16 alpha-cyanopregnenolone treatment. Acta Pharmacol Toxicol (Copenh) (1980) 0.77
Increased binding of quinidine to serum albumin and lipoproteins in anuric rats. Eur J Pharmacol (1975) 0.77
Pharmacokinetics of midazolam and alfentanil in outpatient general anesthesia. A study with concomitant thiopentone, flumazenil or placebo administration. Acta Anaesthesiol Scand (1988) 0.76
Labetalol in the treatment of hypertension in patients with normal and impaired renal function. Acta Med Scand Suppl (1982) 0.75
Serum albumin and lipoproteins as the quinidine binding molecules in normal human sera. Biochem Pharmacol (1976) 0.75
Volatile anesthetics and drug serum protein binding. Anesthesiology (1987) 0.75
Drug metabolizing enzymes in the rat after inhalation of halothane and enflurane. Different pattern of response in liver, kidney and lung and possible implications for toxicity. Br J Anaesth (1983) 0.75
Binding of tiaprofenic acid to human sera and isolated serum proteins. Arzneimittelforschung (1985) 0.75
The use of flumazenil after total i.v. anaesthesia with midazolam in out-patients. Eur J Anaesthesiol Suppl (1988) 0.75
Accumulation and distribution of aliphatic (n-nonane), aromatic (1,2,4-trimethylbenzene) and naphthenic (1,2,4-trimethylcyclohexane) hydrocarbons in the rat after repeated inhalation. Pharmacol Toxicol (1990) 0.75
Short term inhalation of bromobenzene: methodology and absorption characteristics in mouse, rat and rabbit. Pharmacol Toxicol (1990) 0.75
Metabolism and alkylating activity of thio-TEPA in rat liver slice incubation. Cancer Chemother Pharmacol (1991) 0.75
Displacement of some basic drugs from human serum proteins by enflurane, halothane and their major metabolites. An in vitro study. Br J Anaesth (1984) 0.75
Effects of chlorinated paraffins on rat liver microsomal activities and morphology. Importance of the length and the degree of chlorination of the carbon chain. Arch Toxicol (1981) 0.75
Circulating steroids in male rats following inhalation of n-alcohols. Arch Toxicol Suppl (1985) 0.75
Species differences in short term toxicity from inhalation exposure to bromobenzene. Arch Toxicol (1990) 0.75
Steady state pharmacokinetics of tiaprofenic acid in elderly patients. Arzneimittelforschung (1985) 0.75
In vitro screening for metabolic interactions among frequently occurring binary mixtures of volatile organic chemicals in Norwegian occupational atmosphere. Pharmacol Toxicol (1998) 0.75
Inhalation of isopropanol: induction of activating and deactivating enzymes in rat kidney and liver. Increased microsomal metabolism of n-hexane. Toxicology (1985) 0.75
The influence of salts and differences in protein isolation procedure on the binding of quinidine to human serum albumin. Biochem Pharmacol (1976) 0.75
Changes in rat liver morphology and metabolic activities after exposure to chlorinated paraffins. Dev Toxicol Environ Sci (1980) 0.75
Optimization and application of the head space liver S9 equilibration technique for metabolic studies of organic solvents. Pharmacol Toxicol (1998) 0.75
Phthalate esters. II. Effects of inhaled dibutylphthalate on cytochrome P-450 mediated metabolism in rat liver and lung. Arch Toxicol (1984) 0.75
Prediction of in vivo metabolic clearance of 25 different petroleum hydrocarbons by a rat liver head-space technique. Arch Toxicol (2000) 0.75
Biochemical and cytological studies of rat lung after inhalation of methanol vapour. Toxicol Lett (1983) 0.75
Prolonged elimination of midazolam after i.m. administration. Acta Anaesthesiol Scand (1988) 0.75
Induction of cytochrome P-450 in the rat liver after exposure to xylenes, dose-response relationship and dependence on endocrine factors. Toxicology (1983) 0.75
Enzyme induction in liver, kidney and lung after inhalation of halothane and enflurane. Dev Toxicol Environ Sci (1983) 0.75
Oral intake of a toluene-containing thinner. Effects and headspace gas chromatographic analytical diagnosis. Arch Toxicol Suppl (1985) 0.75
Binding and distribution of restrictively and non-restrictively eliminated drugs to serum and liver cell cytosol: effects of volatile anaesthetics. Br J Anaesth (1986) 0.75
Inhalation kinetics of C6 to C10 aliphatic, aromatic and naphthenic hydrocarbons in rat after repeated exposures. Pharmacol Toxicol (1992) 0.75
Glutathione and glutathione S-transferases in rat liver after inhalation of halothane and enflurane. Toxicol Lett (1984) 0.75
Inhalation of enflurane and halothane at subanesthetic concentrations and effects on circulating serum testosterone, luteinizing hormone and follicle-stimulating hormone in the male rat. Toxicol Lett (1983) 0.75
Phthalate esters: effects of orally administered dibutylphthalate on cytochrome P-450 mediated metabolism in rat liver and lung. Acta Pharmacol Toxicol (Copenh) (1986) 0.75
Allometric species comparison of toluene and n-hexane metabolism: prediction of hepatic clearance in man from experiments with rodent liver S9 in a head space vial equilibration system. Pharmacol Toxicol (1998) 0.75
Qualitative alterations of cytochrome P-450 in mouse liver microsomes after administration of acrylamide and methylmethacrylate. Acta Pharmacol Toxicol (Copenh) (1978) 0.75
Absorption of quinidine from an enteric-coated preparation. Eur J Clin Pharmacol (1979) 0.75
Comparison and in vivo relevance of two different in vitro head space metabolic systems: liver S9 and liver slices. Pharmacol Toxicol (1997) 0.75
Regio-selectivity of purified forms of rabbit liver microsomal cytochrome P-450 in the metabolism of benzo(a)pyrene, n-hexane and 7-ethoxyresorufin. Acta Pharmacol Toxicol (Copenh) (1981) 0.75
Circulating concentrations of testosterone, luteinizing hormone and follicle stimulating hormone in male rats after inhalation of methanol. Arch Toxicol Suppl (1984) 0.75
Inhalation of butanols: changes in the cytochrome P-450 enzyme system. Arch Toxicol Suppl (1985) 0.75